ArticleCancer causes & control : CCC2026
Bridging gaps in breast cancer clinical trial enrollment: insights from a community-based research registry initiative.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCancer research registries are critical for ensuring representative participation in clinical trials. However, registries based primarily in hospitals may under-enroll women and other populations who experience structural, logistical, cultural, and informational barriers to care and research participation. Community-based organizations (CBOs) may help address this gap by developing registries that engage diverse populations of women at increased risk for and surviving with breast cancer more directly. The purpose of this study was to examine demographic, clinical, and organizational (i.e., engagement related) factors associated with women's interest in joining a CBO-led breast cancer research registry to support clinical trial access and representation.
methodsSecondary analyses were conducted on repeated cross-sectional surveys (2022-2024) administered to women who contacted a national breast cancer-focused CBO for information and support (n=2,389). Measured variables included demographics, cancer risk, quality of life, patient navigation, empowerment, CBO care quality, social media use, and interest in registry participation; bivariate tests, ANOVAs, and MANCOVAs were used to assess associations.
resultsNearly half of women expressed interest in joining the registry (46.2%), while 17.0% were unsure and 36.8% declined. Interest was greater among younger women, those at higher cancer risk, and those who had a more beneficial experience with the CBO (e.g., better patient navigation, greater empowerment, higher care quality). Greater digital engagement with the CBO (e.g., webinar attendance, frequent social media use, and viewing the CBO's social media content) was also strongly associated with registry interest (p<0.05).
conclusionsCBOs have a unique role in fostering breast cancer research participation. Specific digital approaches (i.e., educational webinars, regularly updated social media content, online pathways that allow interested or uncertain individuals to request follow-up) may extend trusted CBO relationships into registry recruitment and help broaden representation in clinical trials.
Indexed as
Identifiers
42920021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.